Glycated albumin market

Glycated Albumin Market, by Product Type (Human Glycated Albumin and Animal Glycated Albumin), by Application (Diagnosis (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes)) and Research), by End User (Hospitals/Clinics, Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Request Free Sample

Jul 2018
CMI1957
192 Pages
Excel & Pdf
Clinical Diagnostic

Summary

Glycation is the process of bonding of a sugar molecule. For instance, glucose to a protein or a lipid molecule such as albumin. Glycated albumin is glucose bonded to an albumin molecule. Protein molecule i.e. albumin is present in the blood, major body organs, and body fluids. Function of albumin is to maintain shape of the cell and distribute hormones and nutrients.

The amount of albumin decreases in the body when blood glucose levels are low, whereas increases when blood glucose levels are high. Glycated albumin is measured during initiation of diabetes therapies to determine medication dose for treatment of diabetes.

According to a study conducted by American Association for Clinical Study, in 2011, glycated albumin is described as a novel biomarker for the detection and management of diabetes. Treatment of diabetes requires glycemic control. There are various measurements used to provide indicators, which include glycated hemoglobin (HbA1c), 1, 5-anhydroglucitol (1,5AG), and glycated albumin.

Glycated hemoglobin (HbA1c) indicates the glycemic level during the first three months of diabetes incidence. This measurement is useful for the confirmation of short-term therapeutic efficacy during initiation of the treatment for diabetes.

Increasing number of approvals of novel glycated albumin products in the market is expected to fuel the glycated albumin market growth in the near future

In 2015, Asahi Kasei Pharma Corporation received CE Marking for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit, for glycated albumin (GA-L) in Europe. Lucica Glycated Albumin-L is used for the quantitative measurement of glycated albumin in human serum on compatible clinical chemistry analyzers. In 2015, Lucica Glycated Albumin-L received approval in Taiwan, in 2013 it received approval in Indonesia, and Korea.

In 2011, Diazyme Laboratories, Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay Kit received approved by the U.S. Food and Drug Administration (FDA). Enzymatic glycated serum protein (GSP, Glycated Albumin) assay is two part liquid stable reagent, which can be used with various types of automated clinical chemistry analyzers. This product provides additional diagnostic values to clinical practices in diabetes management and screening. Thus, increasing approval of novel glycated albumin kits launched by key players in the market is expected to create a lucrative environment for the global glycated albumin market growth.

The global glycated albumin market value was US$ XX Mn in 2017, and is expected to witness a CAGR of XX% over the forecast period (2018 – 2026).

Figure 1. Global Glycated Albumin Market Share (%), By Region, 2017

Source: Coherent Market Insights Analysis (2018)

Increasing prevalence of diabetes is expected to fuel the glycated albumin market growth

According to the International Diabetes Federation (IDF), the global diabetic population in 2015 was around 415 million and is expected to reach 642 million by 2040. Thus, rising prevalence of diabetes is expected to increase the demand for glycated albumin for its diagnosis, which in turn is expected to fuel the global glycated albumin assay market growth over the forecast period.

North America is expected to hold a dominant position in the global glycated albumin kits market due to high prevalence of diabetes in region. For instance, according to data published by American Diabetes Association in 2015, around 1.25 million children and adults in the U.S. were suffering from type 1 diabetes and around 84.1 million people aged 18 years and above had prediabetes.

Asia Pacific glycated albumin market is expected to show significant growth owing to increasing number of approvals for novel glycated albumin kits in the region. For instance, in 2015, Lucica Glycated Albumin-L by Asahi Kasei Pharma Corporation received approval in Taiwan. Company also received approval for its Lucica Glycated Albumin-L in Indonesia and Korea.

Key players operating in the global glycated albumin market include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.

Table of Content

Table of Contents

Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Global Glycated Albumin Market, By Product Type, 2016 – 2026 (US$ Mn)

Introduction

Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends

Human Glycated Albumin

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Segment Trends

Animal Glycated Albumin

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)

Global Glycated Albumin Market, By Application, 2016 – 2026 (US$ Mn)

Introduction

Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends

Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Segment Trends
  - Prediabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)

Global Glycated Albumin Market, By End User, 2016 – 2026 (US$ Mn)
- Introduction
  - Market Share Analysis, 2018 and 2026 (%)
  - Y-o-Y Growth Analysis, 2017–2026
  - Segment Trends
- Hospitals/Clinics
  - Introduction

Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)

Diagnostic Centers

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)

Research Institutes

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)

Others

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)

Global Glycated Albumin Market, By Region, 2016 – 2026 (US$ Mn)

Introduction

Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026

North America

Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Application, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)

U.S.
Canada

Europe

Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Application, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)

China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC

Latin America

Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Application, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)

Brazil
Mexico
Argentina
Rest of Latin America

Africa

Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Application, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)

Central Africa
South Africa
North Africa

Middle East

Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Application, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)

GCC
Israel
Rest of Middle East

Competitive Landscape

Heat Map Analysis
Company Profiles

Asahi Kasei Pharma Corporation

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Lifespan Biosciences

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Biomatik Corporation

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Abbexa Ltd.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

G Biosciences

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

DRG International, Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Amsbio LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Signalway Antibody LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
United States Biological
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Diazyme Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abnova Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Maccura Biotechnology Co. Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exocell Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biorbyt Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Epinex Diagnostics Inc.

Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 35 market data tables and 32 figures on “Glycated Albumin Market - Global forecast to 2026”.

N/A

- Frequently Asked Questions -

Which are the prominent glycated albumin market players across the globe?

Major players operating in the global glycated albumin market include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.

What are the key factors driving growth of the glycated albumin market?

Increasing number of approvals of novel glycated albumin products in the market is one of the major factors that is expected to propel growth of the market over the forecast period.

Which region is dominating the glycated albumin market growth?

Among regions, North America is expected to hold dominant position in the global glycated albumin market over the forecast period.

Why is North America dominating the glycated albumin market?

North America is dominating the glycated albumin market due to high prevalence of diabetes in region, coupled with rising approvals of novel glycated albumin test in the region.